26th June rns9 Aug 2019 18:21
At the last placing the funds will be used for to advance our lead internal TYK2/JAK1 programmes towards human trails.
We believe we have the potential to generate significant value with these candidates, which represents exciting prospect in the pharmaceutical industry.
This is what I put more money on.
Yes we all read the broads but noth of its true it's all made up to crash the share price so they can get in lower